← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2004Last known activity
Dec 14, 2019
Timeline
1980s
- Jan 1, 1989
Aceragen, Inc/— Founded
2020s
- Oct 9, 2022
Aceragen— Acquired
Drugs by trial phase (15 distinct, 17 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (7 own, 3 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (28)
- NCT04196283CollaboratorPhase 1Dec 14, 2019
- NCT04126876CollaboratorPhase 2Nov 1, 2019
- NCT03865082Lead sponsorPhase 2Jun 30, 2019
- NCT03865082Study directorPhase 2Jun 30, 2019
- NCT03865082OfficialPhase 2Jun 30, 2019
- NCT03445533Lead sponsorPhase 3Feb 28, 2018
- NCT03445533Study directorPhase 3Feb 28, 2018
- NCT03445533OfficialPhase 3Feb 28, 2018
- NCT03052205Study directorPhase 1May 1, 2017
- NCT03052205Lead sponsorPhase 1May 1, 2017
- NCT02644967Study directorPhase 1/Phase 2Dec 1, 2015
- NCT02644967Lead sponsorPhase 1/Phase 2Dec 1, 2015
- NCT02612857Lead sponsorPhase 2Nov 1, 2015
- NCT02612857Study directorPhase 2Nov 1, 2015
- NCT02363439Study directorPhase 1/Phase 2Nov 1, 2014
Details
- Founded
- Cambridge, MA, US Jan 1, 1989
- Last known activity
- Dec 14, 2019